Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension

About the authors

K P Ivanov

Viktoriya Borisovna Mychka

M Yu Kirillova

Irina Evgen'evna Chazova

K P Ivanov

V B Mychka

M J Kirillov

I E Chazova

References

  1. Чазова И.Е., Мычка В.Б. Метаболический синдром. М., 2008.
  2. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996; 334: 374-81
  3. Filer JS. Leptin resistance and obesity. Presented at the 60 th Scientific Sessions of the american diabetes association. June 13, 2000. San-Antonio, Texas.
  4. Диагностика и лечение метаболического синдрома. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2007; 6(6).
  5. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2008; 7(6).

Statistics

Views

Abstract - 20

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies